Cargando…

Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation

OBJECTIVE: To determine whether extending initial prednisolone treatment from eight to 16 weeks in children with idiopathic steroid sensitive nephrotic syndrome improves the pattern of disease relapse. DESIGN: Double blind, parallel group, phase III randomised placebo controlled trial, including a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Webb, Nicholas J A, Woolley, Rebecca L, Lambe, Tosin, Frew, Emma, Brettell, Elizabeth A, Barsoum, Emma N, Trompeter, Richard S, Cummins, Carole, Deeks, Jonathan J, Wheatley, Keith, Ives, Natalie J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531851/ https://www.ncbi.nlm.nih.gov/pubmed/31335316 http://dx.doi.org/10.1136/bmj.l1800

Ejemplares similares

Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based Analysis
por: Afentou, Nafsika, et al.
Publicado: (2022)

Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial
por: Christian, Martin T., et al.
Publicado: (2021)

Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial
por: Webb, Nicholas J A, et al.
Publicado: (2014)

Duration of initial prednisolone therapy for first episode of childhood nephrotic syndrome based on time to response
por: Tang, Xiaoshan, et al.
Publicado: (2022)

Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome
por: Schijvens, Anne M., et al.
Publicado: (2018)

Effect of prednisolone on linear growth in children with nephrotic syndrome()
por: Valavi, Ehsan, et al.
Publicado: (2018)

Deflazacort Versus Prednisolone: Randomized Controlled Trial in Treatment of Children With Idiopathic Nephrotic Syndrome
por: Singhal, Ravish, et al.
Publicado: (2015)

Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson’s disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial
por: Scobie, Sarah, et al.
Publicado: (2021)

A randomized study on a 3-month versus a 7-month prednisolone regimen for the initial episode of childhood idiopathic nephrotic syndrome at a large Saudi center
por: Al Talhi, AbdulHadi, et al.
Publicado: (2018)

Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol
por: Ottridge, Ryan, et al.
Publicado: (2017)

Effectiveness of a Low Dose Prednisolone Regimen for Treatment of Relapses in Children with Steroid Sensitive Nephrotic Syndrome
por: Mantan, Mukta, et al.
Publicado: (2022)

Effectiveness of a Low Dose Prednisolone Regimen for Treatment of Relapses in Children with Steroid Sensitive Nephrotic Syndrome
por: Kalra, Suprita, et al.
Publicado: (2023)

The Growth Hormone Deficiency (GHD) Reversal Trial: effect on final height of discontinuation versus continuation of growth hormone treatment in pubertal children with isolated GHD—a non-inferiority Randomised Controlled Trial (RCT)
por: Brettell, Elizabeth, et al.
Publicado: (2023)

First episode of nephrotic syndrome with acute abdominal pain
por: Goyal, Samridhi, et al.
Publicado: (2020)

Clinico-pathological correlations of congenital and infantile nephrotic syndrome over twenty years
por: Kari, Jameela A., et al.
Publicado: (2014)

Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis
por: Zimmermann-Nielsen, Erik, et al.
Publicado: (2005)

Analysis of continuous biochemical parameters in long-term trials of chronic disease where outcomes could be affected by further intervention
por: Ives, Natalie, et al.
Publicado: (2015)

Short- and long-term efficacy of prednisolone for first acute rhinovirus-induced wheezing episode
por: Jartti, Tuomas, et al.
Publicado: (2015)

Complete remission induced by tacrolimus and low-dose prednisolone in adult minimal change nephrotic syndrome: A pilot study
por: Kim, Yong Chul, et al.
Publicado: (2012)

Short Course of Daily Prednisolone During Upper Respiratory Tract Infection for Children With Relapsing Steroid Sensitive Nephrotic Syndrome
por: Mathew, Joseph L., et al.
Publicado: (2022)

Effects of Antiepileptic Drug Tapering on Episodic Memory as Measured by Virtual Reality Tests
por: Höller, Yvonne, et al.
Publicado: (2020)

Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper
por: Mifflin, Mark D, et al.
Publicado: (2017)

Preliminary Study on Treatment Outcomes and Prednisolone Tapering after Marine Lipid Extract EAB-277 Supplementation in Dogs with Immune-Mediated Hemolytic Anemia
por: Mektrirat, Raktham, et al.
Publicado: (2023)

Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial
por: Gray, Richard, et al.
Publicado: (2021)

Steroid treatment for the first episode of childhood nephrotic syndrome: comparison of the 8 and 12 weeks regimen using an individual patient data meta-analysis
por: Schijvens, Anne M., et al.
Publicado: (2021)

A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
por: Yoshikawa, Norishige, et al.
Publicado: (2015)

Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema
por: Lehtinen, Pasi, et al.
Publicado: (2007)

Nephrotic-Range Proteinuria and Peripheral Edema in a Child: Not Only Idiopathic Nephrotic Syndrome
por: Dolcemascolo, Valentina, et al.
Publicado: (2016)

Cases of aquaporin-4-positive neuromyelitis optica spectrum disorder with successful tapering of prednisolone to less than 3 mg/day after satralizumab administration
por: Nakamagoe, Kiyotaka, et al.
Publicado: (2023)

Health economics education in undergraduate medical training: introducing the health economics education (HEe) website
por: Oppong, Raymond, et al.
Publicado: (2013)

The non-immunosuppressive management of childhood nephrotic syndrome
por: McCaffrey, James, et al.
Publicado: (2015)

Comparison of the Efficacy of Combination Therapy of Prednisolone - Acyclovir with Prednisolone Alone in Bell’s Palsy
por: KHAJEH, Ali, et al.
Publicado: (2015)

Prednisolone: Relapse of coronavirus disease-2019 following misuse of prednisolone: case report
Publicado: (2020)

Dipyrone/prednisolone/prednisolone sodium succinate: Acute urticaria and hyperglycaemia: case report
Publicado: (2021)

Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)
por: Hama, Taketsugu, et al.
Publicado: (2018)

Plasma prednisolone measurements in renal transplant patients.
por: Chakraborty, J.
Publicado: (1981)

Socio-economic accounting of inequalities in excess weight: a population-based analysis
por: Candio, Paolo, et al.
Publicado: (2023)

Intrathecal drug delivery systems for the management of chronic non-cancer pain: protocol for a systematic review of economic evaluations
por: Duarte, Rui V, et al.
Publicado: (2016)

Significance of combined cyclosporine−prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial
por: Saito, Takao, et al.
Publicado: (2013)

Assessment of the Link of ABCB1 and NR3C1 gene polymorphisms with the prednisolone resistance in pediatric nephrotic syndrome patients of Bangladesh: A genotype and haplotype approach
por: Parvin, Most. Nazma, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mbee70dlmndkll5d641cr7h0tc